HyperClear: 양성 전립선 비대증에 대한 레이저 솔루션
양성 전립선 비대증(BPH)을 정밀하게 치료하도록 설계된 첨단 레이저 시스템으로 효과적인 조직 제거, 소변 흐름 개선, 가동 중단 시간 최소화를 통해 환자 치료 결과를 개선합니다.
HyperClear represents an innovative laser therapy system designed to effectively remove surplus prostatic tissue in benign prostatic hyperplasia (BPH). Leveraging the LIFE (Laser-Induced Fiber Enucleation) method, HyperClear applies precise laser energy via a flexible fiber placed transurethrally to the obstructive zone, ablating the excess prostate tissue responsible for lower urinary tract symptoms (LUTS). This approach may be performed outpatient—often with local anesthesia—enhancing patient comfort while maintaining efficacy and safety.
High-Precision Laser Fiber
- Optimized Energy Delivery: The laser fiber is advanced through the urethra to the blocked area, targeting surplus prostate tissue while minimizing collateral damage.
- LIFE Method: Focused on selective tissue vaporization or enucleation, ensuring clean resection planes and predictable tissue removal.
Outpatient Feasibility
- Local Anesthesia: Allows many patients to undergo the procedure without the risks or recovery times associated with general anesthesia.
- Rapid Recovery: Less invasive than conventional transurethral resections, potentially reducing hospital stays and improving patient throughput.
Real-Time Visualization
- Precise Tissue Identification: Endoscopic imaging guides the laser fiber to the obstructive tissue, ensuring thorough clearance of the prostatic urethra.
- Controlled Ablation: The surgeon can finely tune laser energy to match the tissue’s vascularity and density, limiting the risk of deep thermal damage.
Efficient & Gentle Tissue Removal
- Targeted Laser Ablation: Precisely removes hyperplastic prostate segments that hinder urine flow, preserving healthy tissue zones.
- Hemostatic Effect: Laser energy also cauterizes small vessels during tissue vaporization, reducing intraoperative bleeding.
임상적 이점 및 애플리케이션
Benign Prostatic Hyperplasia (BPH)
- Symptomatic Relief: Alleviates classic LUTS such as frequent urination, weak urine stream, and prolonged emptying times.
- Patient Selection: Suited for patients with moderate-to-severe BPH who seek a less invasive alternative to standard TURP or open prostatectomy.
Minimal Invasiveness
- Outpatient Possibility: Potentially performed under local anesthesia, minimizing hospitalization and facilitating early mobilization.
- Lower Bleeding Risk: Laser-based enucleation or vaporization significantly reduces hemorrhage compared to mechanical resection methods.
향상된 환자 경험
- Shorter Convalescence: Many patients resume daily activities sooner, with less postoperative discomfort or catheterization durations.
- Reduced Need for General Anesthesia: Local or spinal anesthesia lessens systemic risks, beneficial for older or comorbid patients.
Technical Specifications
사양 | 세부 정보 / 값 |
제품 이름 | CytroFIX® Superior Clavicula Plates |
재료 | High-Purity Titanium Alloy (e.g., Ti-6Al-4V ELI) |
Plate Profile | Low-profile, contoured for superior clavicle placement |
Locking Mechanism | Locking or non-locking titanium screws; optional variable-angle locking |
Screw Diameter | 2.7 mm or 3.5 mm (titanium cortical screws, depending on hole specification) |
Plate Thickness | ~2.0–2.5 mm (minimized profile) |
Hole Array | Multiple holes for bridging, compression, or combined fixation patterns |
방사 불투명도 | Titanium visible on fluoroscopy (optional etched markers) |
무균 | Provided non-sterile (autoclavable) or sterile, single use or reusable instrumentation (verify product line) |
유통 기한 | Indefinite if stored properly; reusable within recommended inspection cycles |
임상 적응증 | Midshaft/lateral clavicle fractures requiring superior plating, osteotomies, nonunion correction |
Regulatory Compliance | Conforms to ISO 13485, CE/FDA (region-specific), meets orthopedic implant standards |
Size & Ordering Matrix
Plate Length (mm) | Hole Count | Curvature | Compatible Screw | 제품 코드 | 참고 |
60 | 4 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-60-4-27-Ti | Shorter plate for smaller fractures in lateral or mid-shaft |
70 | 5 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-70-5-27-Ti | Extended coverage for mild to moderate fractures |
80 | 5 | Moderate Superior Bend | 2.7 or 3.5 mm Locking | CFX-SCL-80-5-MX-Ti | Bridges midshaft fractures with variable-angle options |
90 | 6 | Moderate Superior Bend | 3.5 mm Locking/Non-Locking | CFX-SCL-90-6-35-Ti | For larger or multi-fragment fractures requiring robust support |
100 | 7 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-100-7-35-Ti | Accommodates more complex or extended fracture lines |
110 | 8 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-110-8-35-Ti | Longest plate design for challenging multi-segment fractures |
연관 상품
-
연조직 및 간용 NeoAblate 종양 절제 프로브
더 보기최소 침습 종양 절제를 위해 설계된 정밀 엔지니어링 기기로, 제어된 에너지를 전달하여 연조직과 간 종양을 효과적으로 치료하는 동시에 주변의 건강한 조직에 대한 손상을 최소화합니다.
-
ATLAS Drug Eluting Coronary Stent System Cobalt Chromium
더 보기A cobalt-chromium coronary stent delivering durable radial strength 그리고 excellent trackability, suited for 복합 또는 석회화 coronary lesions while ensuring minimal recoil.
-
UroFlow 요관 스텐트
더 보기요류가 막히지 않도록 설계된 이 생체 적합성 스텐트는 요관을 안정적으로 지지하여 비뇨기과적 폐쇄를 관리하는 동안 치유를 촉진하고 편안함을 제공합니다.
-
UroGlide 요관 카테터
더 보기부드럽고 안정적인 탐색을 위해 설계된 이 카테터는 비뇨기과 시술 중 효율적인 배액과 접근을 보장하여 외상을 최소화하고 환자의 편안함을 최적화합니다.